Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients

Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients

ABSTRACT Background: Guideline-based best practice treatment for muscle invasive bladder cancer (MIBC) involves neoadjuvant chemotherapy followed by radical cystectomy (NACRC). Prior studies have shown that a minority of patients receive NACRC and older age and renal function are drivers of non-rec...

Full description

Bibliographic Details
Main Authors: Daniel Au, Eugene K. Lee, Taiye O. Popoola, William P. Parker, Jarron M. Saint Onge, Shellie D. Ellis
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2021-07-01
Series:International Brazilian Journal of Urology
Subjects:
Urinary Bladder Neoplasm
Cystectomy
Neoadjuvant Therapy
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382021000400803&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382021000400803&tlng=en

Similar Items